Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease.

IF 2.3 3区医学 Q2 CRITICAL CARE MEDICINE

Seminars in respiratory and critical care medicine Pub Date : 2024-02-01 Epub Date: 2024-01-09 DOI:10.1055/s-0043-1776913

Matthias J Neuböck, Gunar Günther, Aleksandra Barac, Jesper R Davidsen, Christian B Laursen, Ritesh Agarwal, Inderpaul S Sehgal, Christoph Lange, Helmut J F Salzer

引用次数: 0

Abstract

Post-tuberculosis lung disease (PTLD) has only recently been put in the spotlight as a medical entity. Recent data suggest that up to 50% of tuberculosis (TB) patients are left with PTLD-related impairment after completion of TB treatment. The presence of residual cavities in the lung is the largest risk factor for the development of chronic pulmonary aspergillosis (CPA) globally. Diagnosis of CPA is based on four criteria including a typical radiological pattern, evidence of Aspergillus species, exclusion of alternative diagnosis, and a chronic course of disease. In this manuscript, we provide a narrative review on CPA as a serious complication for patients with PTLD.

查看原文本刊更多论文

慢性肺曲霉菌病是肺结核后肺病的一个重要并发症。

结核病后肺部疾病（PTLD）最近才作为一个医学实体受到关注。最近的数据表明，多达 50% 的肺结核（TB）患者在完成 TB 治疗后会留下与 PTLD 相关的损伤。在全球范围内，肺部存在残留空洞是慢性肺曲霉菌病（CPA）发病的最大风险因素。慢性肺曲霉菌病的诊断基于四个标准，包括典型的放射学模式、曲霉菌证据、排除其他诊断和慢性病程。在本手稿中，我们对CPA作为PTLD患者的一种严重并发症进行了叙述性综述。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Seminars in respiratory and critical care medicine 医学-呼吸系统

CiteScore

6.10

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： The journal focuses on new diagnostic and therapeutic procedures, laboratory studies, genetic breakthroughs, pathology, clinical features and management as related to such areas as asthma and other lung diseases, critical care management, cystic fibrosis, lung and heart transplantation, pulmonary pathogens, and pleural disease as well as many other related disorders.The journal focuses on new diagnostic and therapeutic procedures, laboratory studies, genetic breakthroughs, pathology, clinical features and management as related to such areas as asthma and other lung diseases, critical care management, cystic fibrosis, lung and heart transplantation, pulmonary pathogens, and pleural disease as well as many other related disorders.